Home
Subscription
February 2026 issue
January 2026 issue
BACK ISSUES
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
|
2019 Issues
December 2019 Issue
• Feature: Importing Drugs from Canada is a Flawed "Solution" for Failures in the U.S.
• New Drug Review: Lefamulin acetate (Xenleta)
• Appreciation
• Index for Volume 14, 2019
November 2019 Issue
• Feature: CIGARETTES AND VAPING PRODUCTS - MUCH SMOKE AND RHETORIC, BUT NO ACTION
• New Drug Review: Omadacycline tosylate (Nuzyra)
October 2019 Issue
• Feature: CANNABIS CHAOS
• New Drug Review: Cannabidiol (Epidiolex)
September 2019 Issue
• Feature: Are Generics Really the Same as Brand-Name Medicines?
• New Drug Review: Prucalopride succinate (Motegrity)
August 2019 Issue
• Feature: Judge Richard Leon and CVS
July 2019 Issue
• Feature: Walmart Should Get Out of Pharmacy!
• Table: New Therapeutic Agents Marketed in the United States in 2018
June 2019 Issue
• Feature: They Must be Anonymous, But They Will Not be Silent!
• New Drug Review: Revefenacin (Yupelri)
• Rays of Hope: Congratulations to Mayank Amin and Skippack Pharmacy!
May 2019 Issue
• Feature: "I believe I am a danger to the public working for CVS."
• New Drug Review: Lofexidine hydrochloride (Lucemyra)
Easter 2019 Issue
• Feature: FDA BANS SALE OF NICOTINE!
April 1, 2019 Issue
• Feature: FDA BANS SALE OF NICOTINE!
March 2019 Issue
• Feature: Society, Patients, and our Profession Need Independent Pharmacists!
CHALLENGES AND STRATEGIES
• New Drug Review: Elagolix sodium (Orilissa)
February 2019 Issue
• Feature: CVS-Aetna (continued)
January 2019 Issue
• Feature: Reducing Drug Prices – By Increasing Competition, Increasing Self-care, and Eliminating PBM Fraud and Scams
• New Drug Review: Galcanezumab-gnlm (Emgality)
| |
